These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1141 related items for PubMed ID: 17595048

  • 1. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

  • 2. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM.
    Cancer Res; 2008 Feb 01; 68(3):861-9. PubMed ID: 18245488
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 4. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D, Dubey S, Van Veldhuizen P, Holzbeierlein JM, Tawfik O, Thrasher JB.
    Immunotherapy; 2011 Jun 15; 3(6):735-46. PubMed ID: 21668311
    [Abstract] [Full Text] [Related]

  • 5. Vaccination with a chaperone complex based on PSCA and GRP170 adjuvant enhances the CTL response and inhibits the tumor growth in mice.
    Huo W, Ye J, Liu R, Chen J, Li Q.
    Vaccine; 2010 Aug 31; 28(38):6333-7. PubMed ID: 20637304
    [Abstract] [Full Text] [Related]

  • 6. Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
    Roos AK, Pavlenko M, Charo J, Egevad L, Pisa P.
    Prostate; 2005 Feb 15; 62(3):217-23. PubMed ID: 15389792
    [Abstract] [Full Text] [Related]

  • 7. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT, Yen CF, Shaw SW, Yen TC, Chen YJ, Soong YK, Lai CH.
    Vaccine; 2009 Dec 09; 27(52):7352-8. PubMed ID: 19781679
    [Abstract] [Full Text] [Related]

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 09; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 9. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
    Qin H, Zhou C, Wang D, Ma W, Liang X, Lin C, Zhang Y, Zhang S.
    Immunol Lett; 2005 Jun 15; 99(1):85-93. PubMed ID: 15894116
    [Abstract] [Full Text] [Related]

  • 10. Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.
    Dong L, Zhang X, Ren J, Wu S, Yu T, Hou L, Fu L, Yi S, Yu C.
    Cancer Biother Radiopharm; 2013 Jun 15; 28(5):391-7. PubMed ID: 23701419
    [Abstract] [Full Text] [Related]

  • 11. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
    Li Y, Subjeck J, Yang G, Repasky E, Wang XY.
    Vaccine; 2006 Jun 19; 24(25):5360-70. PubMed ID: 16714072
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.
    Hsu KF, Hung CF, Cheng WF, He L, Slater LA, Ling M, Wu TC.
    Gene Ther; 2001 Mar 19; 8(5):376-83. PubMed ID: 11313814
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
    Marshall DJ, Rudnick KA, McCarthy SG, Mateo LR, Harris MC, McCauley C, Snyder LA.
    Vaccine; 2006 Jan 16; 24(3):244-53. PubMed ID: 16135392
    [Abstract] [Full Text] [Related]

  • 14. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X, Yang X, Li L, Liu H, Liu J.
    Vaccine; 2006 Apr 12; 24(16):3321-31. PubMed ID: 16472546
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P.
    Mol Ther; 2006 Feb 12; 13(2):320-7. PubMed ID: 16185933
    [Abstract] [Full Text] [Related]

  • 16. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
    Qu P, Ma JH, Zhang XM, Huang XJ, Yang XW, Yan-Fang S.
    Indian J Exp Biol; 2010 May 12; 48(5):436-43. PubMed ID: 20795360
    [Abstract] [Full Text] [Related]

  • 17. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
    Yamaoka A, Guan X, Takemoto S, Nishikawa M, Takakura Y.
    J Control Release; 2010 Mar 19; 142(3):411-5. PubMed ID: 19913062
    [Abstract] [Full Text] [Related]

  • 18. Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.
    Lu Y, Mekoo DJ, Ouyang K, Hu X, Liu Y, Lin M, Jin L, Cao R, Li T, Zhang Y, Fan H, Liu J.
    Endocr Relat Cancer; 2009 Dec 19; 16(4):1171-84. PubMed ID: 19648182
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
    Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC.
    Cancer Res; 2000 Feb 15; 60(4):1035-42. PubMed ID: 10706121
    [Abstract] [Full Text] [Related]

  • 20. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.